The emergency rule comes just one day before a planned hearing between the DOH and the AIDS Healthcare Foundation.

Dar es Salaam. Health practitioners in Tanzania are optimistic after the official registration of Lenacapavir, a long-acting ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data at ...

Starting Sunday, the state will cut its subsidies for the AIDS ​Drug Assistance Program (ADAP), and funds will only be available for people at or below 130% of the federal poverty level, a drop from ...

The Florida Department of Health has issued emergency rules that could sharply restrict access to HIV medications for ...

In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...

Phase 3 trial results show BIC/LEN is noninferior to BIC/FTC/TAF for maintaining virologic suppression in adults with HIV.

Kenya's health authorities have begun administering lenacapavir, a long-acting HIV prevention drug delivered by injection ...

The Global Fund has committed an additional Sh256 million ($2 million) to support Kenya’s rollout of the long-acting HIV ...

Samson Mutua, 27, is the first Kenyan to receive Lenacapavir, a long-acting HIV prevention injection, marking a significant ...

Kenya has officially launched Lenacapavir, a groundbreaking long-acting injectable for HIV prevention, marking a major step in strengthening the country's response to the epidemic.Health Cabinet ...